ArticleFrontiers in oncology2026

Continuing immune checkpoint inhibitors beyond progression versus switching to non-ICI therapy in advanced gastric cancer: a real-world study.

Guangxi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.